[Side effects and early complications following cervical priming with prostaglandin F2 alpha (PGF2 alpha) in inducing abortion in young women in their 1st pregnancy].
By the application of the priming with 2.5 mg Minprostin F2 alpha a statistically provable dilatation of the cervix in comparison with another group can be achieved. But the priming does not yet effect the occurrence of early complications of the interruption in comparison with conventional methods. In is to be supposed that this method has got a protecting effect on the occurrence of latent late complications of the interruption. Because of the secondary effects of prostaglandins the indication for softening of the cervix should be applied to a very limited range of patients only.
D000028:Abortion, Induced / Q000379:methods*; D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects; D015237:Dinoprost; D005260:Female; D006801:Humans; D010298:Parity; D011247:Pregnancy; D011460:Prostaglandins F / Q000009:adverse effects*; D014590:Uterine Contraction / Q000187:drug effects; D014592:Uterine Hemorrhage / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D011460:Prostaglandins F; D015237:Dinoprost
Nebenwirkungen und Frühkomplikationen nach Zervixreifung mit Prostaglandin F2 alpha (PGF2 alpha) bei der Interruptio junger erstgravider Frauen.